We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Neuroimaging Helps Differentiate Dementia from Depression

By MedImaging International staff writers
Posted on 10 Mar 2017
Print article
Image: Representative brain SPECT scans in Alzheimer\'s dementia and depression (Photo courtesy of Amen Clinics).
Image: Representative brain SPECT scans in Alzheimer\'s dementia and depression (Photo courtesy of Amen Clinics).
A new study suggests that single photon emission computed tomography (SPECT) can help doctors discriminate between depression and cognitive disorders (CDs).

Researchers at Amen Clinics, the University of California, San Francisco, and other institutions conducted a study involving 4,541 patients to evaluate if perfusion neuroimaging with brain SPECT can distinguish between persons with depression from those with CDs (Alzheimer’s disease, vascular dementia, dementia not otherwise specified, and amnestic disorders not otherwise specified), or both conditions.

Of the patients in the study, 847 were diagnosed with a CD, 3,269 were diagnosed with depression, and 425 suffered from both conditions. Using brain SPECT imaging, the researchers calculated perfusion differences between groups, using two-sampled t-tests corrected for multiple comparisons. Diagnostic separation was then determined with discriminant analysis, revealing predictive regions that could help delineate depression from CDs and comorbid cases. For example, the researchers found that people with CDs had lower cerebral perfusion in multiple areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes.

In co-morbid persons, on the other hand, cerebral hypoperfusion was additive, showing lower regional cerebral blood flow compared to either diagnosis alone. They also found that SPECT could distinguish depression from CDs with 86% accuracy, and that brain SPECT imaging showed the ability to distinguish depression or dementia in people with both conditions with 83% accuracy. Feature selection identified the most predictive regions, which were the left hippocampus, right insula, cerebellar, and frontal lobe regions. The study was published on February 10, 2017, in Journal of Alzheimer's Disease.

“Cognitive impairment is present in approximately half of persons who have late onset depression, and depression is evident in 9-65% of individuals with dementia,” concluded lead author psychiatrist Daniel Amen, MD. “It is often challenging to diagnostically disentangle depression and cognitive disorders from one another. These disorders have very different prognoses and treatments, and being able to improve diagnostic accuracy can improve outcomes for some patients.”

Related Links:
Amen Clinics

X-ray Diagnostic System
FDX Visionary-A
Digital X-Ray Detector Panel
Acuity G4
New
Pocket Fetal Doppler
CONTEC10C/CL
Ultrasound Table
Women’s Ultrasound EA Table

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

MRI

view channel
Image: An MRI scan can reveal a heart’s functional age (Photo courtesy of 123RF)

New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes

Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.